Aptose Biosciences

About:

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class

Website: https://aptose.com/

Top Investors: Hanmi Pharmaceutical, Cowen Group

Description:

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.

Total Funding Amount:

$178M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

1986-01-01

Contact Email:

info(AT)lorusthera.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-08-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai